Defiance ETFs’s HCA Healthcare HCA Stock Holding History

Defiance ETFs’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-542	Closed	-$256K	–	398
2026 Q1	$256K	Buy	+542	New	+$273K	﹤0.01%	322

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Defiance ETFs's HCA Position: Q2 2026 in Review

Defiance ETFs sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 542 shares — an estimated $256K sold.

Defiance ETFs first reported a position in HCA in Q1 2026 and held it in 1 quarter. The position peaked at $256K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Defiance ETFs reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Defiance ETFs sold 542 HCA Healthcare shares in Q2 2026, an estimated $256K.
Defiance ETFs first reported a position in HCA Healthcare in Q1 2026 and held it in 1 quarter.
Defiance ETFs's HCA Healthcare position peaked at $256K in Q1 2026.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.